|
US7078042B2
(en)
|
1995-09-15 |
2006-07-18 |
Uab Research Foundation |
Pneumococcal surface protein C (PspC), epitopic regions and strain selection thereof, and uses therefor
|
|
US6245335B1
(en)
|
1996-05-01 |
2001-06-12 |
The Rockefeller University |
Choline binding proteins for anti-pneumococcal vaccines
|
|
JP2002503087A
(ja)
*
|
1996-11-12 |
2002-01-29 |
リージェンツ オブ ザ ユニバーシティ オブ ミネソタ |
ストレプトコッカス・ニューモニアのｃ３結合タンパク質
|
|
DE19708537A1
(de)
*
|
1997-03-03 |
1998-09-10 |
Biotechnolog Forschung Gmbh |
Neues Oberflächenprotein (SpsA-Protein) von Streptococcus pneumoniae etc.
|
|
US6676943B1
(en)
|
1997-04-24 |
2004-01-13 |
Regents Of The University Of Minnesota |
Human complement C3-degrading protein from Streptococcus pneumoniae
|
|
AU2004200125B2
(en)
*
|
1998-04-07 |
2006-07-27 |
Med Immune, Inc. |
Derivatives of Pneumococcal Choline Binding Proteins for Vaccines
|
|
DE69942176D1
(de)
*
|
1998-04-07 |
2010-05-06 |
Medimmune Llc |
Choline-bindende proteine derivate aus pneumokoken als impfstoff
|
|
IL138939A0
(en)
*
|
1998-04-07 |
2001-11-25 |
St Jude Childrens Res Hospital |
A polypeptide comprising the amino acid of an n-terminal choline binding protein a truncate, vaccine derived therefrom and uses thereof
|
|
US6858706B2
(en)
|
1998-04-07 |
2005-02-22 |
St. Jude Children's Research Hospital |
Polypeptide comprising the amino acid of an N-terminal choline binding protein a truncate, vaccine derived therefrom and uses thereof
|
|
US20010016200A1
(en)
|
1998-04-23 |
2001-08-23 |
Briles David E. |
Pneumococcal surface protein C (PspC), epitopic regions and strain selection thereof, and uses therefor
|
|
US6495139B2
(en)
|
1998-11-19 |
2002-12-17 |
St. Jude Children's Research Hospital |
Identification and characterization of novel pneumococcal choline binding protein, CBPG, and diagnostic and therapeutic uses thereof
|
|
WO2000029434A2
(en)
*
|
1998-11-19 |
2000-05-25 |
St. Jude Children's Research Hospital |
PNEUMOCOCCAL CHOLINE BINDING PROTEINS, CbpG AND CbpD, DIAGNOSTIC AND THERAPEUTIC USES THEREOF
|
|
EP1140157B1
(en)
|
1998-12-21 |
2009-02-18 |
MedImmune, Inc. |
Streptococcus pneumoniae proteins and immunogenic fragments for vaccines
|
|
ATE459373T1
(de)
|
1999-03-19 |
2010-03-15 |
Glaxosmithkline Biolog Sa |
Impfstoff gegen kapsulare polysaccharide von streptococcus pneumoniae
|
|
GB9918319D0
(en)
|
1999-08-03 |
1999-10-06 |
Smithkline Beecham Biolog |
Vaccine composition
|
|
GB0022742D0
(en)
*
|
2000-09-15 |
2000-11-01 |
Smithkline Beecham Biolog |
Vaccine
|
|
US20060057160A1
(en)
|
2002-08-02 |
2006-03-16 |
Ralph Biemans |
Vaccine composition
|
|
CA2503946C
(en)
|
2002-11-01 |
2016-08-16 |
Glaxosmithkline Biologicals S.A. |
Drying process
|
|
EP1667712B1
(en)
|
2003-10-02 |
2010-07-21 |
GlaxoSmithKline Biologicals S.A. |
B. pertussis antigens and use thereof in vaccination
|
|
GB0505996D0
(en)
|
2005-03-23 |
2005-04-27 |
Glaxosmithkline Biolog Sa |
Fermentation process
|
|
TWI457133B
(zh)
|
2005-12-13 |
2014-10-21 |
Glaxosmithkline Biolog Sa |
新穎組合物
|
|
KR101515078B1
(ko)
|
2005-12-22 |
2015-04-24 |
글락소스미스클라인 바이오로지칼즈 에스.에이. |
백신
|
|
GB0607088D0
(en)
|
2006-04-07 |
2006-05-17 |
Glaxosmithkline Biolog Sa |
Vaccine
|
|
MY150105A
(en)
|
2006-01-17 |
2013-11-29 |
Forsgren Arne |
A novel surface exposed haemophilus influenzae protein (protein e; pe)
|
|
CA2690708A1
(en)
|
2007-06-26 |
2008-12-31 |
Glaxosmithkline Biologicals S.A. |
Vaccine
|
|
ES2553113T3
(es)
|
2008-04-16 |
2015-12-04 |
Glaxosmithkline Biologicals S.A. |
Vacuna
|
|
WO2010126146A1
(ja)
*
|
2009-04-30 |
2010-11-04 |
Tanaka Noriaki |
腎疾患重篤度を判定する方法又は装置若しくはその作動方法
|
|
GB201003924D0
(en)
|
2010-03-09 |
2010-04-21 |
Glaxosmithkline Biolog Sa |
Immunogenic composition
|
|
CA2792687A1
(en)
|
2010-03-10 |
2011-09-15 |
Glaxosmithkline Biologicals S.A. |
Immunogenic composition
|
|
GB201015132D0
(en)
|
2010-09-10 |
2010-10-27 |
Univ Bristol |
Vaccine composition
|
|
CN103533953A
(zh)
|
2011-05-17 |
2014-01-22 |
葛兰素史密丝克莱恩生物有限公司 |
针对肺炎链球菌的疫苗
|
|
WO2014186796A1
(en)
|
2013-05-17 |
2014-11-20 |
The Board Of Regents Of The University Of Texas System |
Immunization to protect against adverse cardiac events relating to pneumococcal infection
|
|
GB201518684D0
(en)
|
2015-10-21 |
2015-12-02 |
Glaxosmithkline Biolog Sa |
Vaccine
|
|
GB201711635D0
(en)
|
2017-07-19 |
2017-08-30 |
Glaxosmithkline Biologicals Sa |
Immunogenic composition
|
|
EP4061924A1
(en)
*
|
2019-11-18 |
2022-09-28 |
Vaxcyte, Inc. |
Animal product-free culture of streptococcus bacteria
|